Related Experiment Video
Updated: Aug 30, 2025

Author Spotlight: Integrating Tai Chi with Mindfulness Training to Achieve an Effective Mind-Body Exercise
Published on: July 14, 2023
Long-term effects of COVID-19 in diabetic and non-diabetic patients
Ricardo Wesley Alberca1, Yasmim Álefe Leuzzi Ramos1, Nátalli Zanete Pereira1
1Laboratorio de Dermatologia e Imunodeficiencias (LIM-56), Departamento de Dermatologia, Faculdade de Medicina FMUSP, Institute de Medicina Tropical da Universidade de Sáo Paulo, Sáo Paulo, Brazil.
Insights
COVID-19 infection may lead to long-term changes in blood sugar levels, even in non-diabetic individuals. This study tracked COVID-19 patients post-recovery, finding elevated blood glucose and HbA1c in those without prior diabetes diagnoses.
Area of Science:
- Endocrinology
- Infectious Diseases
- Immunology
Background:
- Previous research indicates a link between diabetes, inflammation, and coagulation during COVID-19.
- The long-term effects of COVID-19 on diabetic patients remain under-investigated.
Purpose of the Study:
- To longitudinally analyze COVID-19-associated biomarkers in patients with and without diabetes.
- To assess potential long-term complications following COVID-19 recovery.
- To evaluate changes in glycemic control and inflammatory markers three and six months post-infection.
Main Methods:
- Recruited 128 patients for a longitudinal study.
- Monitored COVID-19-associated biomarkers at three and six months post-recovery.
- Assessed glycemic control (glycemia, glycated hemoglobin) and beta-cell function (c-peptide test).
Main Results:
- No significant long-term modifications in inflammatory biomarkers were observed.
- Non-diabetic patients showed increased glycemia and glycated hemoglobin post-COVID-19.
- Both diabetic and non-diabetic patients exhibited elevated glycated hemoglobin levels.
- C-peptide tests confirmed normal beta-cell function across all participants.
Conclusions:
- COVID-19 may induce transient or lasting alterations in glucose metabolism, particularly in non-diabetic individuals.
- Elevated glycated hemoglobin post-COVID-19 warrants further investigation into potential long-term metabolic complications.
- Beta-cell function appears preserved in most patients after COVID-19, irrespective of diabetes status.
Abstract:
The literature presents several reports of the impact of glycemic control and diabetes in the inflammatory and coagulatory response during coronavirus disease 2019 (COVID-19). Nevertheless, the long-term impact of the COVID-19 in diabetic patients is still to be explored. Therefore, we recruited 128 patients and performed a longitudinal analysis on COVID-19-associated biomarkers of patients with COVID-19, tree and 6 months after COVID-19 recovery and put into perspective the possible long-term complication generated after COVID-19. In our investigation, we failed to verify any long-term modification on inflammatory biomarkers, but detected an increase in the glycemia and glycated hemoglobin in patients without any pre-existing history or diagnosis of diabetes (non-diabetic patients). Although diabetic and non-diabetic patients presented elevated levels of glycated hemoglobin, the c-peptide test indicated a normal beta cell function in all patients.
More Related Videos
04:36Author Spotlight: Understanding Retinal Vessel Resilience and Disease Progression
Published on: January 12, 2024
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Overview of Carbohydrate Metabolism
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...